Abstract:Objective To construct a novel enhanced green fluorescent protein (EGFP) tagged Hela cell subline. Methods EGFP gene fragment was amplified from pEGFP-C1 vector and confirmed by PCR and gene sequencing. pEGFP-C1 vector DNA was isolated and purified by Qiagen tip 500 for transfection into Hela cells. After Hela cells were transfected with pEGFP-C1 by cellfectin reagent, single cell clones were isolated by the selective medium containing geneticin (G418) and limiting dilution in 96-well flat-bottomed culture plates. We replenished the selective media every 3-4 days, and observed the percentage of surviving cells. The fluorescent signal of Hela cells was detected using the convert fluorescent microscope every 24 hours. The character of EGFP was detected with laser confocal microscopy. Results The pEGFP-C1 vector was sequenced and amplified respectively to confirm that EGFP gene was in the correct orientation for expression and contained an ATG and a stop codon. After Hela cells were transfected with the indicated expression pEGFP-C1 vectors 24 hours, the green fluorescence could be found from Hela cells. The intensity of green fluorescence and the number of Hela cells expression green fluorescence increased steadily until 80% Hela cells, after 72 hours. From then on, Hela cells were cultured with selective media containing G418 while untransfected Hela cells were killed. This process took up to 4 weeks. EGFP-labeled Hela cells displayed green fluorescence under fluorescent microscopy and showed high-level stable expression of EGFP. The excitation peak of EGFP was at 395nm (blue), and its emission peak was at 509nm (green) for laser confocal microscopy. Conclusion The high-level stable EGFP-expressing Hela cell line (HeLa-EGFP) provided a simple and reliable tool for studying human cervical cancer in vivo. It may be valuable for further study on molecular mechanisms of cervical cancer metastasis.

Construction of enhanced green fluorescent (EGFP) tagged Hela cell subline

Construction of Retroviral Vector Containing Enhanced Green Fluorescent Protein Gene Driven by Human Telomerase Reserve Transcriptase Gene Promoter and Expression in Human Cervical Cancer Hela Cell

THE ENHANCED GREEN FLUORESCENT PROTEIN AS A MARKER FOR HUMAN TUMOR CELLS LABELLED BY RETROVIRAL TRANSDUCTION

Construction of Recombinant Plasmid Pegfp-Anxa5 and Its Expression in Hela Cells

Establishment of a Gastric Cancer Cell Line Marked by Green Fluorescent Protein

Construction of Mammalian Cell Expression Vector for HLA-A*0201 and EGFP Fusion Protein and Its Expression and Localization in K562 Cells

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector

Construction of Eukaryotic Expression Vector Lip-pEGFP and Its Expression in Hela Cells

[Establishment of A Myelodysplastic Syndrome Transformed to Leukemia Cell Line Stably Expressing Green Fluorescent Protein].

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

[Construction and Expression of Retroviral Vector Encoding Enhanced Green Fluorescent Protein]

[Establishment of a Transgenic Cell Line with Stable Expression of Human CD14].

Cloning of Human Endostatin and Its Expression in Hela Cells

Construction of p3×flag-myc-CMV-24-HPV18E6 fusion gene expression vector and its expression in Hela Cells

Construction of a Tumor-Specific Bioluminescent Eukaryotic Expression Vector and Analysis of Its Expression in Vitro and in Vivo

Construction of Recombinant Plasmid PIRES2-HPV18-EGFP and Its Expression in HeLa Cells

Expression of Gfp in Tumor Cells and Fluorescent Examination by Confocal Microscope

Construction and identification of eukaryotic expression plasmid carrying hTERT-P2A-EGFP

Construction and Identification of GFP Expression Vector Combined with CXCL12-KDEL Gene

Construction of Eukaryote Polycistronic Expression Vector and Expression in Hela

Establishment of Green Fluorescent Protein-Expressing Hepatocellular Carcinoma Cell Lines with Different Metastatic Potential: Relevant Models for in Vivo Monitoring of Metastasis and Angiogenesis